Rapp Healthcare has strengthened its grip on the account of global pharmaceutical company Astellas Pharma by being appointed its pan-European corporate brand advertising agency.
The appointment, which comes after a four way pitch, will see. Rapp develop work promoting Astellas’ existing Changing Tomorrow initiative which highlights the company’s resolve to create a brighter future for patients.
The multi-faceted campaign includes the Changing Tomorrow Awards that recognise the outstanding achievements of individuals or teams working in the field of healthcare.
The work, which will be both off and online, is aimed at key stakeholders such as healthcare professionals and healthcare providers, as well as patients and existing and prospective employees.
Astellas Pharma, formed in 2005 from the merger of two Japanese companies, specialises in products for urology, immunology (transplantation), dermatology, cardiology, and infectious diseases. Its HQ is in Japan and it has offices in the US and the Netherlands.
Commenting on the appointment, Astellas Pharma Europe communications director Mindy Dooa says: “Our ethos of Changing Tomorrow is central to the way that we operate and communicating this to our diverse stakeholders is a marketing priority for us this year. We are confident that Rapp can help us to convey our vision effectively to a broad audience as we continue to grow our core franchises in transplantation, urology, anti-infectives, dermatology and pain management and to expand into oncology.”
Rapp Healthcare managing partner John Perkins said: “We already work for Astellas on both its Protopic and Qutenza brands and we are delighted to be able to extend our relationship further with what is an exciting corporate brand advertising brief.”
Rapp Healthcare was launched in October 2004 and is one of the agency’s fastest growing divisions; clients also include Viagra maker Pfizer.
